Foa_Content_of_CDC-RFA-DP-23-0067 Revision.pdf

Centers for Disease Control and Prevention

NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH

PROMOTION

Building Capacity for Chronic Disease Education and Awareness

CDC-RFA-DP-23-0067

07/03/2023

Table of Contents A. Funding Opportunity Description

B. Award Information

C. Eligibility Information

D. Application and Submission Information

E. Review and Selection Process

F. Award Administration Information

G. Agency Contacts

H. Other Information

I. Glossary

Part I. Overview

Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Subscribe" button link to ensure they receive notifications of any changes to CDC-RFA-DP- 23-0067. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry (ATSDR) B. Notice of Funding Opportunity (NOFO) Title:

Building Capacity for Chronic Disease Education and Awareness C. Announcement Type: New - Type 1:

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf.

Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html (See section 45 CFR 46.102(d)).

D. Agency Notice of Funding Opportunity Number:

CDC-RFA-DP-23-0067

E. Assistance Listings Number:

93.945 https://www.grants.gov/ https://www.grants.gov/ https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html

F. Dates:

1. Due Date for Letter of Intent (LOI):

06/01/2023

2. Due Date for Applications:

07/03/2023 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.

3. Due Date for Informational Conference Call:

June 8, 2023

2:30 pm EST

ZoomGov Meeting Information https://cdc.zoomgov.com/j/16165747726?pwd=bmdaakJQN2xYV2Y1RjFlVm4wMkFjZz09

Meeting ID: 161 6574 7726 Passcode: CDEANOFO-1 One tap mobile +16692545252,,16165747726#,,,,*1060111281# US (San Jose) +16468287666,,16165747726#,,,,*1060111281# US (New York)

Dial by your location +1 669 254 5252 US (San Jose) +1 646 828 7666 US (New York) +1 646 964 1167 US (US Spanish Line) +1 669 216 1590 US (San Jose) +1 415 449 4000 US (US Spanish Line)

+1 551 285 1373 US

Meeting ID: 161 6574 7726 Passcode: 1060111281 Find your local number: https://cdc.zoomgov.com/u/acoK5g3Rsy

Join by Skype for Business https://cdc.zoomgov.com/skype/16165747726

Frequently Asked Questions (FAQs) can be found at www.cdc.gov/populationhealth/chronicdiseaseawareness Email your questions to cdawarenessgrant@cdc.gov (cdawarenessgrant@cdc.gov). Questions and answers will be posted to the FAQs.

G. Executive Summary:

1. Summary Paragraph Building Capacity for Chronic Disease Education and Awareness is a competitive grant program to expand and advance CDC’s National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) work with partners to focus on education, outreach, and public awareness activities of a chronic disease that is not currently funded through a CDC appropriations line. Applicants will propose a chronic disease and implement strategies and activities that have the potential to strengthen the science base for prevention, education, and https://www.grants.gov/ https://cdc.zoomgov.com/j/16165747726?pwd=bmdaakJQN2xYV2Y1RjFlVm4wMkFjZz09 https://cdc.zoomgov.com/u/acoK5g3Rsy https://cdc.zoomgov.com/skype/16165747726 http://www.cdc.gov/populationhealth/chronicdiseaseawareness mailto:cdawarenessgrant@cdc.gov https://www.cdc.gov/budget/documents/fy2023/FY-2023-CDC-Operating-Plan.pdf public health awareness that could lead to evidence-based public health interventions to make meaningful improvements in patient outcomes. Recipients will enhance NCCDPHP’s public health impact by implementing the following strategies related to their proposed chronic disease:

1) Data dissemination activities that support awareness for public health professionals; 2) Develop survey tools to fill data gaps 3) Educational activities supporting public awareness; and

4) Educational activities supporting health professional screening, referral, and treatment and/or management. Collecting and disseminating reliable information on the impacts of chronic diseases is necessary to shape effective, evidence-based clinical and population-level approaches for public health impact and health equity.

a. Eligible Applicants:

Open Competition

b. Funding Instrument Type:

G (Grant)

c. Approximate Number of Awards

d. Total Period of Performance Funding:

$5,200,000

e. Average One Year Award Amount:

$325,000

f. Total Period of Performance Length:

4 year(s)

g. Estimated Award Date:

September 29, 2023

h. Cost Sharing and / or Matching Requirements:

No Cost sharing or matching funds are not required for this program. Although no statutory matching requirement for this NOFO exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

Part II. Full Text

A. Funding Opportunity Description

1. Background

a. Overview Chronic diseases are responsible for 7 in 10 deaths each year, and treating people with chronic diseases accounts for many of our nation’s health care costs. Six in 10 adults live with a chronic disease. Treatment and management of chronic diseases can result in adverse outcomes for significant portions of the population living with a disease. CDC’s National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) helps people and communities prevent and manage chronic diseases and promotes health and wellness for all. For example, NCCDPHP funds about 30 separate disease and risk factor prevention programs that are delivered by states, territories, cities, and tribes that address the prevention and treatment of chronic diseases.

Expanding chronic disease activities beyond currently appropriated activities will allow CDC to https://www.cdc.gov/chronicdisease/center/index.htm https://www.cdc.gov/chronicdisease/center/index.htm https://www.cdc.gov/chronicdisease/resources/infographic/chronic-diseases.htm https://www.cdc.gov/chronicdisease/index.htm https://www.cdc.gov/chronicdisease/index.htm https://www.cdc.gov/chronicdisease/programs-impact/budget/index.htm further address diseases that impact patient and population health.

Engaging partners is a foundational public health activity that can result in meaningful patient and population level outcomes. In 2020, Congress recognized CDC’s work with partners to expand public health education and awareness activities that help improve surveillance, diagnosis, and proper treatment for chronic diseases. Congress charged CDC with establishing a new competitive grant program and this grant program is being expanded in 2023. The purpose of this program is to expand and advance CDC's work with partners on education, outreach, and public awareness activities for a variety of chronic diseases for which there is a clear disparity in public and professional awareness and that are not currently funded through the Fiscal Year (FY) 2023 Appropriations Act, as described on CDC's FY 2023 Operating Budget Plan. This approach would strengthen the science base for prevention, education, and public health awareness for a variety of chronic diseases that do not currently have dedicated resources that would lead to meaningful patient outcomes.

b. Statutory Authorities Section 301(a) of the Public Health Service Act, 42 U.S.C. 241(a).

As authorized by H.R. 2617, Consolidated Appropriations Act, 2023 (P.L. 117-328), Division H- Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023, Joint Explanatory Statement https://www.congress.gov/117/crec/2022/12/20/168/198/CREC-2022-12-20-pt2-PgS8553-2.pdf

Chronic Disease Education and Awareness.— The agreement includes an increase to expand this competitive grant program to a variety of chronic diseases not addressed by a specific National Center for Chronic Disease and Prevention and Health Promotion program.

This program is further authorized by Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill, 2023, House Report 117-403, which directed CDC “to expand public health education and awareness activities that help improve surveillance, diagnosis, and proper treatment for chronic diseases. This competitive grant program expands and advances CDC’s work with stakeholders on education, outreach, and public awareness activities for a variety of chronic diseases for which there is a clear disparity in public and professional awareness that are not already specified under CDC in this report.”

https://www.congress.gov/117/crpt/hrpt403/CRPT-117hrpt403.pdf

c. Healthy People 2030 This NOFO supports the following Healthy People 2030 topic areas:

Health Communication

Health Information Technology

Older Adults

People With Disabilities https://www.cdc.gov/budget/documents/fy2023/FY-2023-CDC-Operating-Plan.pdf https://www.congress.gov/117/crec/2022/12/20/168/198/CREC-2022-12-20-pt2-PgS8553-2.pdf https://www.congress.gov/117/crpt/hrpt403/CRPT-117hrpt403.pdf https://health.gov/healthypeople/objectives-and-data/browse-objectives/health-communication https://health.gov/healthypeople/objectives-and-data/browse-objectives/health-it https://health.gov/healthypeople/objectives-and-data/browse-objectives/older-adults https://health.gov/healthypeople/objectives-and-data/browse-objectives/people-disabilities

Health Care

Public Health Infrastructure

Mental Health and Mental Disorders

Respiratory Disease

Sleep

d. Other National Public Health Priorities and Strategies COPD National Action Plan

Healthy Sleep Awareness Project

Developing and Addressing the Public Health Agenda for Psoriasis and Psoriatic Arthritis

National Lymphedema Network Position Papers and Standardized Frameworks for Clinical Education and Practice

e. Relevant Work This Notice of Funding Opportunity (NOFO) builds upon CDC-RFA-DP21-2112, Expanding the National Approach to Chronic Disease Education and Awareness, which currently funds 6 recipients. More information found here on funded recipients Chronic Disease | Population Health (cdc.gov). The intent of this NOFO is to fund chronic diseases not currently funded and complements or fills gaps in CDC’s National Center for Chronic Disease Prevention and Health Promotion’s (NCCDPHP) current priorities. Chronic Disease Center Operating Budget | CDC currently funds about 30 separate disease and risk factor prevention programs that are delivered by states, territories, cities, tribes, non-governmental organizations, and national partners. In addition, CDC leads or co-leads several national initiatives, such as Million Hearts, National Diabetes Prevention Program, and Active People, Healthy Nation.

2. CDC Project Description

a. Approach

Bold indicates period of performance outcome.

CDC-RFA-DP23-0067 Logic Model: Building Capacity for Chronic Disease Education and Awareness

Strategy/Activity Short-term Outcome

Intermediate Outcomes

Long-Term Outcomes (Required)

Strategy 1: Data dissemination for the proposed chronic disease

Increased number of updated national/state indicators reports

Increased number of national and/or state indicator reports disseminated

Increased number of public health professionals who are aware of the public health surveillance data and evidence-based strategies for the proposed chronic disease https://health.gov/healthypeople/objectives-and-data/browse-objectives/health-care https://health.gov/healthypeople/objectives-and-data/browse-objectives/public-health-infrastructure https://health.gov/healthypeople/objectives-and-data/browse-objectives/mental-health-and-mental-disorders https://health.gov/healthypeople/objectives-and-data/browse-objectives/respiratory-disease https://health.gov/healthypeople/objectives-and-data/browse-objectives/sleep https://www.nhlbi.nih.gov/health-topics/education-and-awareness/COPD-national-action-plan%22%20HYPERLINK%20%22https://www.nhlbi.nih.gov/health-topics/education-and-awareness/COPD-national-action-plan http://sleepeducation.org/healthysleep%22%20HYPERLINK%20%22http://sleepeducation.org/healthysleep https://www.cdc.gov/psoriasis/pdf/Public-Health-Agenda-for-Psoriasis.pdf%22%20HYPERLINK%20%22https://www.cdc.gov/psoriasis/pdf/Public-Health-Agenda-for-Psoriasis.pdf https://lymphnet.org/position-papers%22%20HYPERLINK%20%22https://lymphnet.org/position-papers https://lymphnet.org/position-papers%22%20HYPERLINK%20%22https://lymphnet.org/position-papers https://www.cdc.gov/populationhealth/chronicdiseaseawareness/index.htm https://www.cdc.gov/populationhealth/chronicdiseaseawareness/index.htm https://www.cdc.gov/chronicdisease/index.htm

Strategy 2:

Develop survey tools to fill data gaps

Strategy 3:

Develop and disseminate educational activities that support public awareness

Strategy 4:

Develop and disseminate educational activities that support health care professionals

Increased number of survey questions and/or modules for assessing the proposed chronic disease

Increased number of materials and tools available to increase public awareness of the proposed chronic disease

Increased number of media messages about the proposed chronic disease by priority audience

Increased number of materials or tools presenting best practices for screening, referral, and treatment and/or management, including self-management, for health care professionals

Increased number of available curriculum/ learning opportunities regarding best practices for screening, referral, and treatment and/or management, of the proposed chronic to public health professionals

Increased number of informational materials and messages disseminated by media outlet and priority audience

Increased number of best practices and referral options for a proposed chronic disease disseminated to health care professionals

Increased number of people who are aware of information related to prevention, screening, and treatment and/or management of the

Increased number of health care professionals who are aware of tools and best practices for screening, referral, and treatment and/or management options for the disease for health care professionals

i. Purpose The purpose of this NOFO is to expand and advance CDC’s work on education, outreach, and public awareness activities to strengthen the science base for prevention, education, and public health awareness for a variety of chronic diseases that do not currently have dedicated resources that would lead to meaningful patient outcomes. Recipients will focus on data collection and dissemination, education, and public awareness activities that will support effective, evidence-based clinical and population-level approaches to improve health and health equity.

ii. Outcomes All recipients are expected to achieve the following outcomes by the end of the period of performance. These outcomes are bolded in the logic model.

Intermediate outcomes

Increased number of national and/or state indicator reports disseminated to public health professionals

Increased number of informational materials and messages disseminated by media outlet and priority audience

Increased number of best practices and referral options for a proposed chronic disease disseminated to health care professionals

Long-term outcomes

Increased number of public health professionals who are aware of the public health surveillance data and evidence-based strategies for the proposed chronic disease

Increased number of people who are aware of information related to prevention, screening, and treatment and/or management of the proposed chronic disease

Increased number of health care professionals who are aware of tools and best practices for screening, referral, and treatment and/or management options for the

iii. Strategies and Activities Proposed Chronic Disease

The applicant must propose a single chronic disease to focus on during the NOFO period of performance. The proposed chronic disease must meet the definition of a chronic disease. A chronic disease is defined broadly as a condition that lasts 1 year or more and requires ongoing medical attention or limits activities of daily living or both. The proposed chronic disease cannot currently be funded in CDC’s FY23 Congressional budget; it cannot have a dedicated funding line in the FY 2023 Appropriations Act, as described on CDC's FY 2023 Operating Budget Plan.

https://www.cdc.gov/chronicdisease/about/index.htm

CDC will not consider any application that proposes: 1) More than a single chronic disease to focus on during the life of the grant; 2) A proposed chronic disease that does not meet the definition of a chronic disease. A chronic disease is defined broadly as a condition that lasts 1 year or more and requires ongoing medical attention or limits activities of daily living or both; or

3) Arthritis, Heart Disease, Cancer, Stroke, Alzheimer’s Disease and Related Dementias, Diabetes, Epilepsy, Lupus, and Chronic Kidney Disease, or any other chronic disease with a dedicated funding line in the FY 2023 Appropriations Act, as described on CDC's FY 2023 Operating Budget Plan. Any application proposing a chronic disease that meets any of these three (3) criteria will be deemed non-responsive, and it will receive no further review. Applicants must upload a statement that identifies their proposed chronic disease as a PDF file, under miscellaneous attachments, and name the file “Proposed Chronic Disease.” The PDF file should be uploaded to www.grants.gov. Recipients currently funded through CDC-RFA-DP21-2112 are not eligible to apply.

For the proposed chronic disease, the applicant must describe the following:

A public health need for dedicated resources (e.g., percent of population impacted, disproportionate percentages of specific populations impacted, disease outcomes, or quality of life).

The need to assess the chronic disease in the general adult population to improve surveillance, diagnosis, and/or proper treatment.

How strengthening the science base about the proposed chronic disease, including social, behavioral, environmental, and quality of life aspects, will improve awareness, diagnosis, and proper treatment, and improve patient outcomes.

How a focus on the proposed chronic disease will shape or promote evidence-based practices for prevention, education, and public health awareness.

Ability to track the proposed chronic disease in the general adult population to improve surveillance, diagnosis, and proper treatment.

How dedicated funding for the proposed chronic disease has a high potential for the following:

o Population-level impact (e.g., percent of population impacted, disproportionate percentages of specific populations impacted, disease outcomes, or quality of life);

o Increasing awareness and shaping evidence-based practice to improve patient outcomes;

o Strengthening the science base for prevention, education, and public health awareness;

Finally, the applicant must describe that a focus on the proposed chronic disease has a high potential to complement or fill gaps in CDC’s National Center for Chronic Disease Prevention and Health Promotion’s (NCCDPHP) current priorities. NCCDPHP FY 2023 Operating Budget currently funds about 30 separate disease and risk factor prevention programs that are delivered by states, territories, cities, tribes, non-governmental organizations, and national partners.

Applicants must upload a statement that identifies their proposed chronic disease as a PDF file, under miscellaneous attachments, and name the file “Proposed Chronic Disease.” The PDF file should be uploaded to www.grants.gov.

https://www.cdc.gov/chronicdisease/about/index.htm https://www.cdc.gov/budget/documents/fy2023/FY-2023-CDC-Operating-Plan.pdf https://www.cdc.gov/budget/documents/fy2023/FY-2023-CDC-Operating-Plan.pdf https://www.cdc.gov/chronicdisease/index.htm

Proposed Strategies and Activities

Recipients are expected to implement the strategies and activities listed during the period of performance. The strategies and activities build upon each other to strengthen the science base for prevention, education, and public health awareness where there is a clear disparity between public and professional awareness. Recipients will focus on data collection and dissemination, education, and public awareness activities that will support effective, evidence-based clinical and population-level approaches to improve patient outcomes, health, and health equity. Recipients are required to implement all activities listed below and may implement additional activities.

Strategy 1: Data dissemination activities for the proposed chronic disease that support awareness for public health professionals

· Review and compile existing national and state-level measures related to the proposed chronic disease, including prevalence, mortality, related health indicators, risk factors, care-delivery measurements, contextual factors (social, behavioral, environmental), and quality of life (e.g., Chronic Disease Indicators (CDI) | DPH | CDC).

· Review and synthesize information related to evidence-based strategies for addressing the proposed chronic disease, including community programs, practices, and policies.

· Draft or update a national/state indicator report that includes the presentation of measures and evidence-based strategies about the proposed chronic disease.

· Disseminate the National and/or State Indicator Report for the proposed chronic disease to public health professionals.

Strategy 2: Develop survey tools to fill data gaps

· Identify questions from previous health survey or surveillance projects that relate to the proposed chronic disease (such as health care, treatment, management, quality of life, or other topics reflecting experience living with the disease) and review their strengths and weaknesses.

· Where information gaps exist, develop questions appropriate for assessment and/or surveillance of the proposed chronic disease, including contextual factors (social, behavioral, environmental) and quality of life.

· Partner with others to further develop questions and/or modules.

Strategy 3: Develop and disseminate educational activities that support public awareness

· Review and synthesize available informational messages and materials to increase public awareness of the proposed chronic disease.

· Create additional messages and materials where gaps exist, including gaps in content or tailoring for priority audiences.

· Use earned and paid media, online social networks, and other engaging methods to disseminate messages and materials about the proposed chronic disease.

Strategy 4: Develop and disseminate educational activities that support health care professionals in screening, referral, and treatment and/or disease management https://www.cdc.gov/cdi/index.html

· Review, compile, and synthesize the evidence related to best practices for prompt screening, referral, and treatment and/or management options, including self-management, for persons with the proposed chronic disease.

· Identify best practices for prompt screening, referral, and treatment and/or management options, including self-management, related to the proposed chronic disease.

· Identify tools available to promote best practices to health care professionals for use with patients with the proposed chronic disease and their caregivers.

· Create additional education and referral materials or tools for health care providers where gaps exist or where there are limitations in tools' capacity to address barriers or specific audiences.

· Disseminate these materials and/or tools to health care professionals through multiple engaging methods.

1. Collaborations

a. With other CDC projects and CDC-funded organizations:

Collaborations with CDC chronic disease programs or other organizations funded by CDC for chronic diseases is required of recipients. If applicants have not already worked with CDC, include a statement of their willingness to collaborate with CDC, and outline how. As part of the project narrative, applicants should describe prior experience in successful collaborations with CDC NCCDPHP’s programs and/or CDC-funded organizations on national initiatives, objectives, and goals. Applicants should describe past and current collaborations related to the proposed chronic disease. Applicants should describe collaborations with other CDC programs, or CDC-funded organizations that are not chronic disease focused but are implementing similar strategies that demonstrate measurable improvements in patient outcomes and/or population health, are also encouraged. Recipients are encouraged to work with recipients currently funded through CDC-RFA-DP21-2112. Information on currently funded project can be found at Chronic Disease Awareness | Funding (cdc.gov).

b. With organizations not funded by CDC:

Collaborations with a variety of public and private partners are required to leverage resources and maximize reach and impact. To achieve the expected outcomes, the recipient will be required to build and sustain strategic partnerships and collaborations with organizations that have a role in implementing these strategies and activities for the proposed chronic disease across the target audiences (public, health care professionals, and public health professionals).

Key collaborations may include the business community, hospitals, non-governmental organizations, non-profit agencies, other federal, state, or local government agencies, public health community, tribes or tribal organizations, professional organizations, quality improvement organizations, or federally qualified health centers. Applicants should include letters of commitment or MOUs/MOAs from key collaborators that must include specific details on the role they will assume on the project (limit 10 letters). General letters of support are not recommended. The applicant should explain how each collaboration they propose would assist in implementing activities and achieving outcomes. The applicant must describe past and current experience in successful collaborations that support national initiatives, objectives, and goals (e.g., national agendas, Healthy People objectives, state or local health objectives, national https://www.cdc.gov/populationhealth/chronicdiseaseawareness/funding-opportunities/expanding-education-approach-NOFO.html https://www.cdc.gov/populationhealth/chronicdiseaseawareness/funding-opportunities/expanding-education-approach-NOFO.html guidelines and recommendations) related to the proposed chronic disease. Applicants must upload the letters of commitment/MOUs/MOAs as a single PDF file, under miscellaneous attachments, and name the file “Collaboration Letters.” The PDF file should be uploaded to www.grants.gov.

2. Target Populations Public health professionals Public, including people with the proposed chronic disease and their caregivers Health care professionals

a. Health Disparities This NOFO intends to address health disparities through the collection of detailed data on the proposed chronic disease that identifies differences in burden among population groups including contextual factors (e.g., social, behavioral, environmental), and outcomes (e.g., quality of life) as well as gaps in knowledge necessary to create awareness among the public, public health professionals, and health care providers that can shape evidence-based prevention and treatment approaches that improve patient outcomes and decrease health disparities.

iv. Funding Strategy Applicant organizations may only submit one application. If multiple applications are submitted by the same organization, only the application with the latest time stamp will be accepted. Up to four awards will be made to address the strategies and activities identified in the logic model for this NOFO. No more than one (1) award will be made per proposed chronic disease. If multiple applications are received for the same proposed chronic disease and score high enough to be funded, the award will go to the applicant with the highest score. Current CDC-RFA-DP21-2112 recipients are not eligible to apply under this announcement.

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy

Evaluation and performance measurement help demonstrate achievement of NOFO outcomes and effectiveness of NOFO activities. Performance measurement can help to build a stronger evidence base for these strategies and activities as they relate to the proposed chronic disease.

Performance measurement can also clarify applicability of the evidence base to different populations, settings, and contexts to determine if strategies and activities are scalable and effective at reaching target populations. Performance measures and evaluation findings can drive continuous program quality improvement, as well as provide information needed to improve future NOFOs.

CDC will work with recipients to finalize performance measures within the first 6 months after award.

CDC uses these measures to track implementation of each recipient’s strategies and activities (process evaluation) and determine the recipient's progress on achieving the period of performance outcomes (outcome evaluation). Recipients will be required to report on all the following performance measures for the proposed chronic disease.

Performance Measures:

Number of national and/or state indicator reports disseminated to public health professionals.

Number of survey questions and/or modules for assessing the proposed chronic disease.

Number of messages or materials disseminated about the proposed chronic disease by dissemination method and priority audience.

Number of materials or tools disseminated to health care professional that present best practices for screening, referral, and treatment and/or disease management for the proposed chronic disease.

Number of public health professionals who received or accessed the national/state indicator report for the proposed chronic disease.

Number of people who received or accessed messages or materials providing information related to prevention, screening, and treatment and/or disease management of the proposed chronic disease, by media outlet and priority audience.

Number of health care professionals who received or accessed the best practices materials and/or tools for screening, referral, and treatment and/or disease management related to the proposed chronic disease.

Outcome Performance Measure

Intermediate Outcome-Increased number of national and/or state indicator reports disseminated to public health professionals

1. Number of national and/or state indicator reports disseminated to public health professionals.

2. Number of public health professionals who received or accessed the national/state indicator report for the proposed chronic disease.

Long-Term Outcome-Increased number of public health professionals who are aware of the public health surveillance data and evidence-based strategies for the proposed chronic disease

1. Number of survey questions developed for assessing the proposed chronic disease in total.

2. Number of public health professionals who are aware of the public health surveillance data and evidence-based strategies for the proposed chronic disease.

Long-Term Outcome-Increased number of people who are aware of information related to prevention, screening, and treatment and/or management of the proposed chronic disease

1. Number of people who received or accessed messages or materials providing information related to prevention, screening, and treatment and/or disease management of the proposed chronic

2. Number of messages or materials disseminated about the proposed chronic

Intermediate Outcome-Increased number of informational materials and messages disseminated by media outlet and priority audience

1. Number of people who received or accessed messages or materials providing information related to prevention, screening, and treatment and/or disease management of the proposed chronic disease by media outlet.

2. Number of people who received or accessed messages or materials providing information related to prevention, screening, and treatment and/or disease management of the proposed chronic disease by media outlet by priority audience.

Intermediate Outcomes-Increased number of best practices and referral options for a proposed chronic disease disseminated to health care professionals

1. Number of health care professionals who received or accessed the best practices materials and/or tools for screening, referral, and treatment and/or disease management related to the proposed chronic disease.

Long-Term Outcome-Increased number of health care professionals who are aware of tools and best practices for screening, referral, and treatment and/or management options for the proposed chronic disease

1. Number of materials or tools disseminated to health care professional that present best practices for screening, referral, and treatment and/or disease management for the proposed chronic disease.

"Since this NOFO does not involve the generation or collection of public health data, a Data Management Plan (DMP) is not required for this NOFO.”

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How the applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant)

Plans for updating the Data Management Plan (DMP) as new pertinent information becomes available. If applicable, throughout the lifecycle of the project. Updates to DMP should be provided in annual progress reports. The DMP should provide a description of the data that will be produced using these NOFO funds; access to data;

data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans. For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additional-requirements/ar-25.html.

Where the applicant chooses to, or is expected to, take on specific evaluation studies, the applicant should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, if applicable, within the first 6 months of award, as described in the Reporting Section of this NOFO.

c. Organizational Capacity of Recipients to Implement the Approach The applicant should describe their role as a recognized leader for the proposed chronic disease.

Applicants must describe experience and expertise working on the national level for the proposed chronic disease. Applicants must adequately describe their organization’s capacity to successfully implement the strategies and activities and achieve the expected outcomes as outlined in this NOFO. Applicants must have adequate infrastructure (physical space, technology), financial management systems (budget management and administration), and qualified and competent staff with appropriate skills (data management, communications, education).

Applicants must include an organizational chart for the organization and where the program will be housed within the organization. Applicants must submit the organizational chart(s) as a pdf attachment, name the file “Organizational Chart”, and upload to www.grants.gov.

Applicants must adequately describe their organization’s capacity and expertise, unless otherwise noted, for the following. Examples and impact of experiences are encouraged.

Years of experience your organization has related to the proposed chronic disease.

Describe major accomplishments working on the national level for the proposed chronic disease.

Past and current experience and impact of successful collaborations that support national initiatives, objectives, and goals (e.g., national agendas, Healthy People objectives, state https://www.cdc.gov/grants/additional-requirements/ar-25.html or local health objectives, and national guidelines and recommendations) related to the proposed chronic disease.

Partnerships with national, state, and/or local groups/organizations relevant to the proposed chronic disease.

Accessing, compiling, reviewing, synthesizing, and disseminating data related to the proposed chronic disease.

Developing survey tools to fill data gaps, including any partnerships on these activities.

Developing and disseminating health information messages, materials, and tools for the public and people living with the condition and their caregivers to increase awareness and improve patient outcomes.

Describe experience with social media, conducting media buys, creating earned media, and other engaging methods used to increase awareness of the proposed chronic disease.

Identifying, evaluating, and disseminating best practices to support health care professionals in screening, referral, and treatment and/or management, including self-management, to improve patient outcomes related to the proposed chronic disease.

Past and current experience with accessing provider education venues and relationships with professional associations to conduct professional educational activities.

Core project management, including the roles and responsibilities of project staff and their day-to-day responsibility for key tasks, such as project leadership, project monitoring, preparation of reports, and program evaluation. Include resumes for staff assigned to this project as a single file and upload it as a miscellaneous attachment titled “Resumes” to www.grants.gov.

Ability to fill positions quickly with competent, qualified staff. If staff positions are vacant, explain how and when those positions will be filled. Include job descriptions for positions that are to be filled as a single pdf titled “Job Descriptions” and upload it as a miscellaneous attachment to www.grants.gov.

Describe any potential contractual or consultant agreements with a significant role in implementing program strategies and achieving project outcomes.

Describe your organization’s financial management systems and processes for proper funds management (e.g., separation of funds by program, monitoring funds by program and financial staff), issuing and monitoring contracts, and meeting the requirements as stated in the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS awards: Electronic Code of Federal Regulations (eCFR). The financial systems and processes should allow the preparation of reports required by general and program-specific terms and conditions; and the tracing of funds to a level of expenditure adequate to establish that such funds have been used according to the federal statutes, regulations, and terms and conditions of the federal award.

d. Work Plan Applicants should provide a detailed work plan and include all data elements listed in the table in text for the first year of the project and describe in the project narrative a high-level work plan for subsequent years.

The detailed work plan:

https://www.ecfr.gov/cgi-bin/text-idx?SID=dfb89e372a4aaf623ce41affce47c0cf&mc=true&tpl=/ecfrbrowse/Title45/45tab_02.tpl

1. Aligns with the program logic model,

2. Aligns with the period of performance outcomes and performance measures provided.

Period of Performance Outcome: (from Outcomes section and/or logic model)

Outcome Measure: (from Evaluation and Performance Measurement section)

Strategy #: Title (from logic model)

Activities (from logic model)

Process Measures (from Evaluation and Performance Measurement section)

Responsible Position / Person / Collaborator (be specific)

Completion Date (month/year)

1.

2.

3.

4.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and recipients, site visits, and recipient reporting (including work plans, performance, and financial reporting).

Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking recipient progress in achieving the desired outcomes.

Ensuring the adequacy of recipient systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities deemed necessary to monitor the award:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that recipients are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with recipients on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk recipients.

B. Award Information

1. Funding Instrument Type:

G (Grant)

2. Award Mechanism:

U58 Chronic Disease Control Cooperative Agreement

3. Fiscal Year:

4. Approximate Total Fiscal Year Funding:

$1,300,000

5. Total Period of Performance Funding:

$5,200,000 This amount is subject to the availability of funds.

Estimated Total Funding:

$5,200,000

6. Total Period of Performance Length:

4 year(s) year(s)

7. Expected Number of Awards:

8. Approximate Average Award:

$325,000 Per Budget Period

9. Award Ceiling:

$400,000 Per Budget Period

This amount is subject to the availability of funds.

10. Award Floor:

$300,000 Per Budget Period

11. Estimated Award Date:

September 29, 2023

12. Budget Period Length:

12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total period of performance comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Direct Assistance Direct Assistance (DA) is not available through this NOFO.

If you are successful and receive a Notice of Award, in accepting the award, you agree that the award and any activities thereunder are subject to all provisions of 45 CFR part 75, currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.

C. Eligibility Information

1. Eligible Applicants

Eligibility Category:

00 (State governments)

01 (County governments)

02 (City or township governments)

04 (Special district governments)

05 (Independent school districts)

06 (Public and State controlled institutions of higher education)

07 (Native American tribal governments (Federally recognized))

08 (Public housing authorities/Indian housing authorities)

11 (Native American tribal organizations (other than Federally recognized tribal governments))

12 (Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education)

13 (Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education)

20 (Private institutions of higher education)

22 (For profit organizations other than small businesses)

23 (Small businesses)

25 (Others (see text field entitled "Additional Information on Eligibility" for clarification))

99 (Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility")

Additional Eligibility Category:

Government Organizations:

State governments or their bona fide agents (includes the District of Columbia)

Local governments or their bona fide agents

Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau

State controlled institutions of higher education

American Indian or Alaska Native tribal governments (federally recognized or state-recognized)

Non-government Organizations

American Indian or Alaska native tribally designated organizations

Other

Ministries of Health

2. Additional Information on Eligibility

“Bona fide agents are eligible to apply. For more information about bona fide agents, please see the CDC webpage on Expediting the Federal Grant Process with an Administrative Partner located at https://www.cdc.gov/publichealthgateway/grantsfunding/expediting.html#Q2.”

CDC will not consider any application that proposes: 1) More than a single chronic disease to focus on during the life of the grant; 2) A proposed chronic disease that does not meet the definition of a chronic disease. A chronic disease is defined broadly as a condition that lasts 1 year or more and requires ongoing medical attention or limits activities of daily living or both; or 3) Arthritis, Heart Disease, Cancer, Stroke, Alzheimer’s Disease and Related Dementias, Diabetes, Epilepsy, Lupus, and Chronic Kidney Disease, or any other chronic disease with a dedicated funding line in the FY 2023 Appropriations Act, as described on CDC’s FY 2023 operating budget plan found here: Fiscal Year 2023 CDC Operating Plan. Any application proposing a chronic disease that meets any of these three (3) criteria will be deemed non-responsive, and it will receive no further review. Applicants must upload a statement that identifies their proposed chronic disease as a PDF file, under miscellaneous attachments, and name the file “Proposed Chronic Disease.”

Recipients currently funded through CDC-RFA-DP21-2112 are not eligible to apply.

The award ceiling for this NOFO is $400,000. CDC will consider any application requesting an award higher than this amount non-responsive, and it will receive no further review.

The award floor for this NOFO is $300,000. CDC will consider any application requesting an award lower than this amount non-responsive, and it will receive no further review.

https://www.cdc.gov/publichealthgateway/grantsfunding/expediting.html#Q2.

https://www.cdc.gov/chronicdisease/about/index.htm

Additional guidance for Ministries of Health applicants.

When completing the SF-424 Ministry of Health applicants must select option: “X: Other (specify)” from the drop-down list in block 9. Next the Ministry of Health applicant will be prompted to fill-in the “Other"(specify) field. The applicant should describe their organization as a Ministry of Health in this field.

3. Justification for Less than Maximum Competition

N/A

4. Cost Sharing or Matching

Cost Sharing / Matching Requirement:

No Cost sharing or matching funds are not required for this program. Although no statutory matching requirement for this NOFO exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

5. Maintenance of Effort

Maintenance of effort is not required for this program.

D. Application and Submission Information

1. Required Registrations

An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

PLEASE NOTE: Effective April 4, 2022, applicants must have a Unique Entity Identifier (UEI) at the time of application submission (SF-424, field 8c). The UEI is generated as part of SAM.gov registration. Current SAM.gov registrants have already been assigned their UEI and can view it in SAM.gov and Grants.gov. Additional information is available on the GSA website, SAM.gov, and Grants.gov- Finding the UEI.

a. Unique Entity Identifier (UEI):

All applicant organizations must obtain a Unique Entity Identifier (UEI) number by registering in SAM.gov prior to submitting an application. A UEI number is a unique twelve-digit identification number assigned to the registering organization.

If funds are awarded to an applicant organization that includes sub-recipients, those sub-recipients must provide their UEI numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into https://www.grants.gov/ https://www.gsa.gov/about-us/organization/federal-acquisition-service/office-of-systems-management/integrated-award-environment-iae/iae-systems-information-kit/unique-entity-identifier-update https://sam.gov/content/home https://grantsgovprod.wordpress.com/2021/09/14/how-to-find-an-applicants-uei-within-grants-gov/ https://grantsgovprod.wordpress.com/2021/09/14/how-to-find-an-applicants-uei-within-grants-gov/ which an entity must submit information required to conduct business as a recipient.